PF-04634817

DB14955InvestigationalSmall molecule

PF-04634817 is under investigation in clinical trial NCT01140672 (A Multiple Dose Study To Determine Safety, Tolerability, and Pharmacokinetics Of PF-04634817 In Healthy Adult Subjects).

Mechanism: Pharmacologically active on C-C chemokine receptor type 5 and C-C chemokine receptor type 2
Curator reviewed
Formula / weight: C₂₅H₃₆F₃N₅O₃ · 511.59 g/mol (avg)
Code names: PF-04634817

Resolves to

Compound

UNII51M3FB9B9ECAS1228111-63-4

Structure

InChIKeyMCRWZBYTLVCCJJ-DKALBXGISA-NSMILESCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1C[C@@H]2C[C@H]1CN2C1=NC=NC(=C1)C(F)(F)F

Targets

P51681CCR5P41597CCR2

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with PF-04634817, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account